Aug 21, 2025
Kinomica Expands IP Portfolio to 45 Granted Patents with New Assignments from QMUL, Strengthening Leadership in Phosphoproteomics
Read more →

January 14, 2025
Michele Pedrocchi Appointed Chair of Kinomica
Read more →
September 19, 2024
Advanced Method for Predicting Response to Midostaurin plus Chemotherapy in Acute Myeloid Leukaemia Greatly Outperforms Current Companion Diagnostic
Read more →
May 31, 2024
Kinomica Announces Multiple Abstracts on its KScan® Precision Oncology Diagnostic Platform to be Presented at the 72nd Annual Meeting of the American Society for Mass Spectrometry
Read more →
May 29, 2024
Kinomica to Present Research Abstract on a Multi-drug Biomarker Signature to Predict Best First-line Treatments for Acute Myeloid Leukemia (AML) at the 2024 ASCO Annual Meeting
Read more →
May 28, 2024
Kinomica, King’s College London and King’s College Hospital NHS Foundation Trust to Present Research Abstract at the 2024 ASCO Annual Meeting
Read more →